Table 1. Study to define the best cutoff point for the screening questionnaire.
Cutoff point | Probability of diagnosis of lipedema | 95% confidence interval | Sensitivity | Specificity | Prevalence in the study population |
---|---|---|---|---|---|
5 | 21.9% | 12.7-35.2% | 1 | 0.593 | 51.0% (129) |
6 | 28.7% | 18.4-41.8% | 0.94 | 0.644 | 42.3% (107) |
7 | 36.6% | 25.5-49.4% | 0.9 | 0.695 | 37.2% (94) |
8 | 45.3% | 33.6-57.6% | 0.88 | 0.729 | 30.4% (77) |
9 | 54.3% | 42.0-66.1% | 0.78 | 0.780 | 24.9% (63) |
10 | 63.0% | 50.1-74.3% | 0.66 | 0.831 | 19.4% (49) |
11 | 71.0% | 57.5-81.5% | 0.58 | 0.831 | 15.0% (38) |
12 | 77.8% | 64.2-87.3% | 0.46 | 0.880 | 12.3% (31) |
13 | 83.4% | 70.1-91.5% | 0.38 | 0.949 | 7.9% (20) |
14 | 87.8% | 75.2-94.5% | 0.26 | 0.966 | 4.7% (12) |
15 | 91.2% | 79.6-96.5% | 0.18 | 0.966 | 4.7% (12) |
16 | 93.7% | 83.3-97.8% | 0.06 | 0.983 | 3.2% (8) |
17 | 95.5% | 86.4-98.6% | 0.04 | 1.000 | 2.4% (6) |